mirt0 | 11986
Mirtazapin
| Material |
|
|
| Note |
Blood sampling immediatly before administration of the next dose. Therapeutic range refers to trough level. | 4-Methylaminoantipyrine, a metabolite of metamizole, interferes with the determination of mirtazapine. Both substances are eluted together. Falsely increased mirtazapine concentrations are therefore possible with conmedication. |
|
| Stability | 2 days / 18-25°C; 2 weeks / 2-8°C; 2 weeks / -20°C | |
| Duration | 4 days | |
| Frequency | 2 x per week | |
| Method | Liquid chromatography / mass spectrometry (LCMS) | |
| Price | CHF 126.00 | |
| Tariff | 126.00 TP | |
| LA position | 1065.00 | |
| Designation | Antidepressiva der SL/ALT inkl. Metaboli |
Reference values
| Value | Sex |
|---|---|
| 113 - 302 nmol/L | f+m |
Team of consultants
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
PhD
Maurus Curti
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology
|
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology | T |
|
|
PharmD
Sarah Molteni
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
MD
Uta Deus
Specialist in General Internal Medicine, FAMH Specialist in laboratory medicine, main field clinical chemistry
|
Specialist in General Internal Medicine, FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|